US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings

The summary for the US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.

US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings: Influenza and other respiratory illnesses, including COVID-19, are important causes of morbidity, mortality, and healthcare burden across all age groups. For influenza and novel vaccines, such as for COVID-19, estimates of vaccine effectiveness in preventing illness and associated complications are needed in order to evaluate the protection provided by nationwide vaccination programs. The goal of this notice of funding opportunity is to support a network of US institutions that can: a) conduct systematic testing for laboratory-confirmed disease due to influenza, SARS-CoV-2 and other respiratory virus infections, b) obtain reliable vaccination information for enrolled patients and c) provide accurate estimates of the effectiveness of vaccines against respiratory viruses, including influenza and SARS-CoV-2 and other respiratory viruses, to prevent medically attended influenza-associated illness in the population for whom vaccination is recommended.

Federal Grant Title:	US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings
Federal Agency Name:	Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-IP-22-004
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.083, 93.185
CFDA Descriptions:	Information not provided
Current Application Deadline:	May 9th, 2022
Original Application Deadline:	May 9th, 2022
Posted Date:	March 8th, 2022
Creation Date:	March 8th, 2022
Archive Date:	June 8th, 2022
Total Program Funding:	$107,500,000
Maximum Federal Grant Award:	$9,100,000
Minimum Federal Grant Award:	$2,000,000
Expected Number of Awards:	8
Cost Sharing or Matching:	No
Last Updated:	March 17th, 2022

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: N/A
Grant Announcement Contact: Amy Yang
[email protected]
[email protected]
Similar Government Grants: • Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Su...; • Collaborative research on influenza and other respiratory pathogens in South Africa; • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...; • Nationwide Cohort to Estimate Burden of Respiratory Viruses and Immunologic Response (Bloo...; • Network of Community Cohorts for Monitoring Changes in Respiratory Virus Epidemiology (Pan...; • Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia...; • Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infections in a...; • Economic Studies of Immunization Policies and Practices
More Grants from the Centers for Disease Control and Prevention ERA: • Rigorously Evaluating Primary Prevention Strategies for Intimate Partner Violence and Sexu...; • Formative Research of Community-led Primary Prevention Approaches to Address Elevated Risk...; • Rigorous Evaluation of Primary and Secondary Overdose Prevention Activities Among Populati...; • Effectiveness Research to Prevent Polysubstance-Impaired Driving; • Grants to Support New Investigators in Conducting Research Related to Preventing Interpers...